• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/10

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

10 Cards in this Set

  • Front
  • Back
short duration insulin
need to eat when you take it
int. duration insulin
take after meal
long duration insulin
daily med
Tolbutamide
oral hypoglycemics
sulfonylureas 1st generation

stimulates release of insulin from pancreas

duration of action is shorter than 2nd generation

SE: hypoglycemia, weight gain
Glipizide
oral hypoglycemic
sulfonylurea 2nd generation

typically have a longer duration of action and can be given 1/day

SE: hypoglycemia, weight gain
Repaglinide
oral hypoglycemic
meglitinide

stimulates pancreas to release insulin

must take before or w/meal b/c have a rapid peak and may induce hypoglycemia

SE: also weight gain
Metformin
oral hypoglycemic
biguanide

dec. production of glucose by liver,
inc. glucose uptake,
utilization of muscles

slow absorption, renal elim

SE: GI, no weight gain or risk of hypoglycemia
Acarbose
oral hypoglycemic
alpha-glucosidase inhibitors

delays asorption of dietary carbs in intestines = reduce rise of glucose after meals

inhibits alpha-glucosidase = breaks down carbs for absorption

SE: GI, no weight gain or hypoglycemia
Rosiglitazone
oral hypoglycemics
Thiazolidinediones (glitazones)

dec. insulin resistance
PPARY agonist: nucleus receptor that regulates genes important for glucose met. and sensitivity

SE: weight gain (water retention); may exacerbate CHF, hepatitis, liver failure
Exenatide
oral hypoglycemic

incretin mimetic = binds to receptors, slows gastric emptying, stimulates insulin release, inhibits post-prandial glucose release, suppresses appetite

SE: acute pancreatitis, renal impairment, GI, hypoglycemia if taken w/sulfonylurea